Auto-HTAP - centre maladies rare cochin

26. Servettaz A, Tamby MC, Guilpain P, Reinbolt J, Garcia de la Pena-Lefebvre
P, Allanore Y, et al., Anti-endothelial cell antibodies from patients with
limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-
B). Clin Immunol 2006; 120: 212-9.
27. Tamby MC, Chanseaud Y, Humbert M, Fermanian J, Guilpain P, Garcia-dela-Pena-Lefebvre
P, et al., Anti-endothelial cell antibodies in idiopathic and
systemic sclerosis associated pulmonary arterial hypertension. Thorax 2005;
60: 765-72.
28. Chizzolini C, Raschi E, Rezzonico R, Testoni C, Mallone R, Gabrielli A, et
al., Autoantibodies to fibroblasts induce a proadhesive and proinflammatory
fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum
2002; 46: 1602-13.
29. Henault J, Tremblay M, Clement I, Raymond Y , Senecal JL, Direct binding
of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts
in patients with systemic sclerosis. Arthritis Rheum 2004; 50: 3265-74.
30. Henault J, Robitaille G, Senecal JL , Raymond Y, DNA topoisomerase I
binding to fibroblasts induces monocyte adhesion and activation in the
presence of anti-topoisomerase I autoantibodies from systemic sclerosis
patients. Arthritis Rheum 2006; 54: 963-73.
31. Tamby MC, Humbert M, Guilpain P, Servettaz A, Dupin N, Christner JJ, et
al., Antibodies to fibroblasts in idiopathic and scleroderma-associated
pulmonary hypertension. Eur Respir J 2006; 28: 799-807.
32. Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, et
al., Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N
Engl J Med 2006; 354: 2667-76.
33. Casciola-Rosen L, Wigley F , Rosen A, Scleroderma autoantigens are
uniquely fragmented by metal-catalyzed oxidation reactions: implications
for pathogenesis. J Exp Med 1997; 185: 71-9.
34. Dorfmuller P, Perros F, Balabanian K , Humbert M, Inflammation in
pulmonary arterial hypertension. Eur Respir J 2003; 22: 358-63.
35. Hoeper MM, Pulmonary hypertension in collagen vascular disease. Eur
Respir J 2002; 19: 571-6.
36. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB , Voelkel NF,
Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J
2005; 26: 1110-8.
37. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G,
et al., Clinical classification of pulmonary hypertension. J Am Coll Cardiol
2004; 43: 5S-12S.
38. Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G , Humbert M,
Pulmonary arterial hypertension: a rare complication of primary Sjogren
syndrome: report of 9 new cases and review of the literature. Medicine
(Baltimore) 2007; 86: 299-315.
39. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, et al.,
Pathologic assessment of vasculopathies in pulmonary hypertension. J Am
Coll Cardiol 2004; 43: 25S-32S.
Auto-HTAP - Version n°1.1 du 19/10/2009 50/56